Clinical Trial Update: Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a targeted busulfan and fludarabine conditioning regimen for hematopoietic stem cell transplantation in Chronic Granulomat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Chronic Granulomatous Disease | Phase 1, Phase 2 | Status: UNKNOWN